These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6287718)

  • 1. Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.
    Bauer G; Höfler P; Zur Hausen H
    Virology; 1982 Aug; 121(1):184-94. PubMed ID: 6287718
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
    Yanase S; Sugawara K
    Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis.
    Bauer G
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1337-46. PubMed ID: 6304236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibition of DNA synthesis on Epstein--Barr virus induction by tumor promoters.
    Yamamoto N; zur Hausen H
    Virology; 1980 Feb; 101(1):104-10. PubMed ID: 6243817
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of activated serum factor on the induction of Epstein-Barr virus antigens and cell differentiation.
    Roubalová K; Anisimová E; Roubal J
    Arch Virol; 1985; 85(1-2):85-94. PubMed ID: 2990391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the expression of Fc receptor produced by induction of Epstein-Barr virus in lymphoma cell lines.
    Yee C; Costa J; Hamilton V; Klein G; Rabson AS
    Virology; 1982 Jul; 120(2):376-82. PubMed ID: 6285610
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
    Anisimová E; Roubalová K; Bauer G; Roubal J
    Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
    Klein G; Vilcek J
    J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibitory effects of retinoic acid on Epstein-Barr virus induction in producer and nonproducer cell lines.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1984; 22(1):56-60. PubMed ID: 6329997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
    Prachová K
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Umeda R; Ogura H; Hatano M
    Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid inhibition of Epstein-Barr virus induction.
    Yamamoto N; Bister K; zur Hausen H
    Nature; 1979 Apr; 278(5704):553-4. PubMed ID: 219367
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
    Roubal J; Luka J; Klein G
    Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arabinofuranosylthymine on Epstein-Barr virus replication.
    Ooka T; Calender A
    Virology; 1980 Jul; 104(1):219-23. PubMed ID: 6249024
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.
    Derge JG; Martos LM; Tagamets MA; Chang SY; Chakrabarty M
    Nat New Biol; 1973 Aug; 244(137):214-7. PubMed ID: 4353682
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of protease inhibitors on the activation of Epstein-Barr virus repressed in cultured lymphoid cells.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1981; 16(1):49-52. PubMed ID: 6276326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
    Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
    Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.